Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies
Kevin H. Chen, Yupo Ma(Macau University of Science and Technology)
Cited by 112
Related Papers
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
|Annals of the Rheumatic Diseases|2024|194
Stem Cell Gene SALL4 Suppresses Transcription through Recruitment of DNA Methyltransferases
|Journal of Biological Chemistry|2011|71
Enhanced self-renewal of hematopoietic stem/progenitor cells mediated by the stem cell gene Sall4
|Journal of Hematology & Oncology|2011|57
Validation of BCMA-CD19 Compound CAR-T Therapy in SLE Overlap Syndrome: Over 1.5-Year Follow-Up
|Stem Cell Reviews and Reports|2025|9